Isabelle Dussault, PhD

Isabelle is a biotech leader with more than 25 years in drug discovery, translational research, biomarkers, and clinical strategy.

 

She specializes in small molecules, drug conjugates, and biologics for oncology and immune oncology. She serves as Chief Scientific Advisor at Therabene. Previously she was Senior Vice President of Research at Fusion Pharmaceuticals, after leading clinical biomarker strategy at EMD Serono and holding director roles in oncology research at Bristol Myers Squibb, Merck, and Amgen.

 

Isabelle earned her PhD in Anatomy and Cell Biology from McGill University and followed by postdoctoral research at Harvard Medical School.